Yeah no, this one's ep lab not my ward, but cleaner ablations means fewer afib patients meeting me in the hf bay five years on. I'll take that trade.
@aoifecardiac.bsky.social
@aoifecardiac.bsky.socialYeah no, this one's ep lab not my ward, but cleaner ablations means fewer afib patients meeting me in the hf bay five years on. I'll take that trade.
@fritzlabsx.bsky.social"ADVOCATing for Patients With Heart Failure" explores autonomous AI agents for heart failure care, targeting FDA clearance and superiority to standard care while raising questions about safety, accountability and funding. #AI #HeartFailure #DigitalHealth jamanetwork.com/journals/jam...
@thelancetendo.bsky.socialRobust trial evidence supports weight loss as a disease-modifying strategy in some conditions, including but not limited to type 2 #diabetes & #heartfailure with preserved ejection fraction www.thelancet.com/journals/lan...
#incretin-based therapies #weightloss #T2D
@northwell-journals.bsky.socialMolecular Medicine - Journal
Article in Press: Three decades of ischemic heart disease–related heart failure in G20 countries: shifting burden, inequalities, and projections to 2050 | #MolecularMedicine #IschemicHeartDisease #HeartFailure #G20 #HealthInequality link.springer.com/article/10.1...
@cvia-journal.orgGlobal impact of #HeartFailure: affects 64M+, has a high mortality rate, like cancer. Effective therapies underused. Editorial urges reorientation for the full potential of #GDMT. #medsky #Cardiology
#CVIA #OpenAccess: doi.org/10.15212/CVI...
@dabishnhs.bsky.social73,701 reports and no device problem found. Genuinely wonder how many are "we don't know" masquerading as "nothing wrong."
@scainews.bsky.social⚡ 7 days to #SCAISHOCK!
Meet multidisciplinary faculty across #InterventionalCardiology, #HeartFailure, #CriticalCare, cardiac surgery, and more. Learn how #CardiogenicShock teams work together to improve care from recognition through recovery.
Register ➡️ scai.org/shock
@cardiobeast.bsky.socialamyloidosis hides in plain. We need to look harder.
@drjcast.bsky.socialClass II recall on neonatal circuits means post-market surveillance caught a pattern, pigtail connector failure in the most vulnerable population. Now the real QMS work starts.
@jmirlatestresearch.bsky.socialJMIR Formative Res: Prompted Text-Based Vital Sign Recording Versus Unprompted Electronic Medical Record Entries in Patients With Advanced Heart Failure: Observational Study #HeartFailure #RemoteMonitoring #PatientEngagement #VitalSigns #DigitalHealth
@cvia-journal.orgThis study shows that early #PalliativeCare (PC) integration in advanced #HeartFailure, standardized triggers & collaboration with home-based PC programs deliver more comprehensive, patient-centered care. #medsky #Cardiology
#CVIA #OpenAccess: doi.org/10.15212/CVI...
@drsarahwh.bsky.socialThe lag between injury and recall is measured in years, not weeks. How many devices are failing silently in our clinics while we're buried in QOF reviews?
@hollerdoc.bsky.social"Sporadic" failure in a neonatal breathing circuit. For a rural hospital running lean, that word doesn't comfort much, it means no backup.
@scilightpress.bsky.social[IJDDP] Alkaloids in Cardiovascular Therapy 🫀
This Review explores how alkaloids may act in heart failure, arrhythmia, hypertension, myocardial infarction, and myocardial fibrosis.
#CardiovascularDisease #Alkaloids #NaturalProducts #HeartFailure #Arrhythmia #Hypertension
@cppeengland.bsky.socialOur new Optimise: Heart failure Optimise programme supports pharmacy professionals to build confidence in using the four pillars of heart failure therapy through shared decision making.
🔗 Learn more here: https://www.cppe.ac.uk/news/a/1118/cppe-optimise-heart-failure
@cvia-journal.orgHow can frontline clinicians ensure timely referral in advanced #HeartFailure?
This overview highlights key signs, referral pathways & the importance of early specialist involvement to improve outcomes. #medsky
#OpenAccess: doi.org/10.15212/CVI...
#CVIA #Cardiology #ClinicalCare
@pharmaphorum.bsky.social#NovoNordisk has opted to discontinue two late-stage trials of IL-6 inhibitor #ziltivekimab in #heartfailure, after an interim look at the data suggested they would be unlikely to show a positive result.
@genesndiseases.bsky.socialCould one splicing regulator shape #HeartFailure?
This study identifies RBM27 as essential for maintaining Tnnt2 splicing and cardiac function, revealing a promising therapeutic target for heart disease. #AlternativeSplicing
#OpenAccess #GenesAndDiseases: doi.org/10.1016/j.ge...
@rositazakeri.bsky.social🫀 Detecting atrial cardiomyopathy is only the start.
The next challenge: can we modify the atrial substrate - and improve patient outcomes?
Our new EJHF Expert Consensus examines the evidence, gaps and path towards disease modification.
@dabishnhs.bsky.social69,424 MAUDE reports Apr-Aug with no identified device problem, alarming; underfunded mean hospitals (and taxpayers) pay later.